Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2003 Oct;74(10):900-5.
doi: 10.1007/s00115-003-1577-3.

[Niemann-Pick disease type C--a neurometabolic disease through disturbed intracellular lipid transport]

[Article in German]
Affiliations
Case Reports

[Niemann-Pick disease type C--a neurometabolic disease through disturbed intracellular lipid transport]

[Article in German]
A J Grau et al. Nervenarzt. 2003 Oct.

Abstract

Niemann-Pick disease type C (NPC) is a rare, neurovisceral lipid storage disorder caused by genetic defects in lipid transporting proteins. It is distinct from Niemann-Pick types A and B (sphingomyelin lipidoses) and displays genetic (mutations in the NPC1 or NPC2[=HE1] gene), biochemical, and clinical heterogeneity. Late infantile to juvenile forms of NPC predominate and are characterised by atypical behaviour, ataxia, dysarthria, dysphagia, dystonia, cataplexy, vertical gaze palsy, splenomegaly, and dementia. In adult variants, psychosis and dementia are common, and dysarthria, ataxia, splenomegaly, and vertical gaze palsy are further facultative signs. Routine laboratory results including serum cholesterol are normal. In bone marrow smears, sea-blue histiocytes are often demonstrated and foam cells sometimes seen. The diagnosis is confirmed by detecting free cholesterol accumulation in perinuclear granules (lysosomes) and reduced cholesterol esterification after challenge with exogenous low-density lipoprotein in fibroblasts. Alternatively or additionally, mutational analysis can be performed. Treatment is restricted to symptomatic measures, since there is no specific therapy.

PubMed Disclaimer

References

    1. Biochim Biophys Acta. 1991 Jun 5;1096(4):328-37 - PubMed
    1. J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):552 - PubMed
    1. J Inherit Metab Dis. 1999 Feb;22(1):84-6 - PubMed
    1. J Inherit Metab Dis. 2002 Sep;25(5):385-9 - PubMed
    1. Hum Mutat. 2002 Jan;19(1):30-8 - PubMed

Publication types

MeSH terms

LinkOut - more resources